143 related articles for article (PubMed ID: 23480370)
1. Anti-laminin γ1 pemphigoid.
Kalkoff EC; Bramsiepe I; Groth S; Marsch WC; Kreft B
J Dtsch Dermatol Ges; 2013 Jun; 11(6):555-7. PubMed ID: 23480370
[No Abstract] [Full Text] [Related]
2. Anti-laminin-γ1 pemphigoid developed in a case of autosomal recessive congenital ichthyosis.
Ohzono A; Numata S; Hamada T; Fukuda S; Teye K; Shirakashi Y; Kasai H; Koga H; Ishii N; Sugiura M; Hashimoto T
Acta Derm Venereol; 2015 Jan; 95(1):93-4. PubMed ID: 24733442
[No Abstract] [Full Text] [Related]
3. Treatment of anti-laminin γ1 pemphigoid with mycophenolate mofetil.
Gawaz A; Metzler G; Hertl M; Hashimoto T; Schaller M
J Dtsch Dermatol Ges; 2015 Jul; 13(7):696-7. PubMed ID: 26058852
[No Abstract] [Full Text] [Related]
4. Generalized annular bullous eruption--quiz case. Anti-laminin γ1 pemphigoid with a linear IgA bullous dermatosis–like presentation.
Myers DJ; Unwala RD; Xia L; Groth S; Zillikens D; Stratman EJ
Arch Dermatol; 2011 Jan; 147(1):109-14. PubMed ID: 21242402
[No Abstract] [Full Text] [Related]
5. Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma.
Kaminaka C; Kanazawa N; Furukawa F; Hashimoto T
J Dermatol; 2010 Mar; 37(3):272-5. PubMed ID: 20507394
[No Abstract] [Full Text] [Related]
6. Subepidermal autoimmune bullous disease affecting predominantly mucocutaneous junctions and the palms with autoantibodies to BP230 and laminin γ1.
Honda Y; Dainichi T; Nishie W; Ujiie H; Hattori Y; Miyachi Y; Kabashima K
Br J Dermatol; 2016 Sep; 175(3):619-21. PubMed ID: 26972908
[No Abstract] [Full Text] [Related]
7. Refractory Pemphigoid with Autoantibodies to Both BP230 and Laminin gamma1.
Ashida H; Hamada T; Hosokawa Y; Hashimoto T; Nishie W; Ishii N; Nakama T; Kanno T; Ikeda M
Acta Derm Venereol; 2019 Nov; 99(12):1172-1173. PubMed ID: 31449311
[No Abstract] [Full Text] [Related]
8. From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.
Dainichi T; Koga H; Tsuji T; Ishii N; Ohyama B; Ueda A; Natsuaki Y; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
J Dermatol; 2010 Mar; 37(3):231-8. PubMed ID: 20507386
[TBL] [Abstract][Full Text] [Related]
9. Another case of dyshidrosiform pemphigoid.
Patrizi A; Rizzoli L; Benassi L; Neri I
J Eur Acad Dermatol Venereol; 2003 May; 17(3):370. PubMed ID: 12702100
[No Abstract] [Full Text] [Related]
10. An uncommon cause of acral vesiculo-bullous eruption.
Galeone M; Bassi A; Scarfì F; Arunachalam M; Sollai M; Difonzo EM
G Ital Dermatol Venereol; 2015 Oct; 150(5):640-1. PubMed ID: 25952283
[No Abstract] [Full Text] [Related]
11. Bullous pemphigoid masquerading as recurrent vesicular hand eczema.
Veien NK
Acta Derm Venereol; 2010; 90(1):4-5. PubMed ID: 20107717
[No Abstract] [Full Text] [Related]
12. Dyshidrosiform pemphigoid localized on the hands in a child: a rare occurrence.
Dayal S; Sahu P; Jain VK
An Bras Dermatol; 2017; 92(5):714-716. PubMed ID: 29166515
[TBL] [Abstract][Full Text] [Related]
13. Bullae of the hands, feet, and perioral area in a 3-month-old infant. Bullous pemphigoid.
Lynch M; Devaney D; Khaw Y; O'Donnell B
Pediatr Dermatol; 2013; 30(1):135-6. PubMed ID: 23316718
[No Abstract] [Full Text] [Related]
14. Anti-laminin-gamma 1 Pemphigoid with Generalized Pustular Psoriasis and Psoriasis Vulgaris.
Fujimura Y; Natsuga K; Hamade Y; Nomura Y; Kaku Y; Muramatsu R; Shimizu H
Acta Derm Venereol; 2016 Jan; 96(1):120-1. PubMed ID: 26074471
[No Abstract] [Full Text] [Related]
15. Case of atypical bullous pemphigoid with generalized pruritus and eczema as the prodrome for 10 years.
Ikeda T; Okamoto K; Furukawa F
J Dermatol; 2012 Aug; 39(8):720-1. PubMed ID: 22011062
[No Abstract] [Full Text] [Related]
16. Clinical and immunological features and outcome of anti-p200 pemphigoid.
Commin MH; Schmidt E; Duvert-Lehembre S; Lasek A; Morice C; Estival JL; Debarbieux S; Rigal E; Pauwels C; De Quatrebarbes J; Roussel A; Goujon E; Stoebner PE; Jouen F; Joly P
Br J Dermatol; 2016 Oct; 175(4):776-81. PubMed ID: 27037896
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide.
Honl BA; Elston DM
Cutis; 1998 Aug; 62(2):85-6. PubMed ID: 9714904
[TBL] [Abstract][Full Text] [Related]
18. An attempt to develop mouse model for anti-laminin γ1 pemphigoid.
Koga H; Ishii N; Dainichi T; Tsuruta D; Hamada T; Ohata C; Karashima T; Furumura M; Hashimoto T
J Dermatol Sci; 2013 May; 70(2):108-15. PubMed ID: 23410740
[TBL] [Abstract][Full Text] [Related]
19. Brunsting-Perry pemphigoid of the scalp with antibodies against laminin 332.
Jedlickova H; Niedermeier A; Zgažarová S; Hertl M
Dermatology; 2011; 222(3):193-5. PubMed ID: 21228551
[No Abstract] [Full Text] [Related]
20. [Dyshidrotic pemphigoid].
Beylot-Barry M; Doutre MS; Beylot C
Ann Dermatol Venereol; 1995; 122(3):81-3. PubMed ID: 7486727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
